Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 121.78 million compared to CNY 108.91 million a year ago. Net loss was CNY 38.28 million compared to CNY 67.52 million a year ago.

Basic loss per share from continuing operations was CNY 0.3143 compared to CNY 0.5544 a year ago. Diluted loss per share from continuing operations was CNY 0.3143 compared to CNY 0.5544 a year ago.